Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.

about

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis.The biologics of ulcerative colitis.Identifying disease-specific distress in patients with inflammatory bowel disease.

P2860

Q37051515-27669BB5-5A46-43A5-8E86-C400D67703C1 Q39037681-0053AE2A-DC9D-4AC9-9276-49A020904B5B Q39654513-2B06EF0C-75D9-468F-BEC6-389D417CBFA6

P2860

Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.

Item

http://www.wikidata.org/entity/Q41293564

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Cerebrovascular events in infl ...... necrosis factor alpha agents.

@en

type

Item

label

Cerebrovascular events in infl ...... necrosis factor alpha agents.

@en

prefLabel

Cerebrovascular events in infl ...... necrosis factor alpha agents.

@en

P1476

Cerebrovascular events in infl ...... necrosis factor alpha agents.

@en

P2093

Airi Jussila

http://www.w3.org/2001/XMLSchema#string

Andy C Y Li

http://www.w3.org/2001/XMLSchema#string

Antonella Scarcelli

http://www.w3.org/2001/XMLSchema#string

Dario Sorrentino

http://www.w3.org/2001/XMLSchema#string

Dino Tarabar

http://www.w3.org/2001/XMLSchema#string

ECCO CONFER investigators

http://www.w3.org/2001/XMLSchema#string

Flavio Steinwurz

http://www.w3.org/2001/XMLSchema#string

Graham D Naismith

http://www.w3.org/2001/XMLSchema#string

Guillaume Bouguen

http://www.w3.org/2001/XMLSchema#string

Henit Yanai

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory bowel disease: an increased risk factor for neurologic complications

Tumor necrosis factor-α modulates cerebral aneurysm formation and rupture.

Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature.

Biochemical and inflammatory biomarkers in ischemic stroke: translational study between humans and two experimental rat models.

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers.

Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage.

Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study.

Multipotent role of platelets in inflammatory bowel diseases: a clinical approach.

Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights.

P304

382-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ECCO-JCC/JJV042

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jan C. Preiß

Konstantinos Karmiris

Peter Bossuyt

Ioannis Zaganas

P577

2015-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273148904

http://www.w3.org/2001/XMLSchema#string

P698

25740813

http://www.w3.org/2001/XMLSchema#string

P921

TNF

inflammatory bowel diseases

Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.

about

P2860

P2860

Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921